Variant report

Variant	nsv481956
Chromosome Location	chr6:162536770-162929715
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:33)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:33 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
2	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:
3	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
4	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
5	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
6	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:
7	chr6:162902802..162905070-chr6:162905406..162907332,2	K562	blood:
8	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
9	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
10	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
11	chr6:162902802..162905070-chr6:162905406..162907332,2	K562	blood:
12	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
13	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
14	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
15	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
16	chr6:162863816..162864618-chr6:163271757..163272511,2	MCF-7	breast:
17	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
18	chr6:162574333..162576032-chr6:162578404..162580150,2	K562	blood:
19	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
20	chr6:162553757..162556831-chr6:162558713..162560436,3	K562	blood:
21	chr6:162553757..162556831-chr6:162558713..162560436,3	K562	blood:
22	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
23	chr6:162863367..162864320-chr6:163157771..163158572,4	MCF-7	breast:
24	chr6:162552000..162556573-chr6:162556763..162561114,5	K562	blood:
25	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:
26	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:
27	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:
28	chr6:162574333..162576032-chr6:162578404..162580150,2	K562	blood:
29	chr6:162258059..162258779-chr6:162552660..162553528,2	MCF-7	breast:
30	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
31	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
32	chr6:162552000..162556573-chr6:162556763..162561114,5	K562	blood:
33	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:

No data

Extended variants
information (count: 16101 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:16101 , 50 per page) page: 1 2 3 4 5 6 7 ... 323

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs117290489	chr6:162536775-162536776	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs181723219	chr6:162536788-162536789	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs531226743	chr6:162536796-162536797	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs544959937	chr6:162536811-162536812	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs35535738	chr6:162536824-162536825	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs561575045	chr6:162536840-162536841	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs79240341	chr6:162536852-162536853	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs546596409	chr6:162536908-162536909	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs35500896	chr6:162536911-162536912	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs532268075	chr6:162537013-162537014	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs551930880	chr6:162537027-162537028	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs6913155	chr6:162537103-162537104	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs537740952	chr6:162537106-162537107	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs185246657	chr6:162537118-162537119	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs112844636	chr6:162537165-162537166	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs536227365	chr6:162537181-162537182	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs190745569	chr6:162537183-162537184	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs9458464	chr6:162537193-162537194	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs376989797	chr6:162537234-162537235	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs573243661	chr6:162537273-162537274	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs545548276	chr6:162537314-162537315	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs556839492	chr6:162537317-162537318	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs139559467	chr6:162537356-162537357	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs79773651	chr6:162537388-162537389	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs544820096	chr6:162537399-162537400	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs561392579	chr6:162537404-162537405	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs142547495	chr6:162537407-162537408	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs546958096	chr6:162537429-162537430	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs560120554	chr6:162537446-162537447	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs77468489	chr6:162537464-162537465	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs35649227	chr6:162537467-162537468	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs181532329	chr6:162537476-162537477	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs112764997	chr6:162537517-162537518	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs201953392	chr6:162537583-162537584	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs77305430	chr6:162537618-162537619	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs73783416	chr6:162537626-162537627	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs115968381	chr6:162537648-162537649	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs546657204	chr6:162537719-162537720	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs566896769	chr6:162537720-162537721	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs186262192	chr6:162537736-162537737	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs559042817	chr6:162537775-162537776	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs575827769	chr6:162537790-162537791	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs191308616	chr6:162537810-162537811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs555178908	chr6:162537823-162537824	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs377489189	chr6:162537830-162537831	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs183093305	chr6:162537861-162537862	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs9456744	chr6:162537866-162537867	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs559884852	chr6:162537868-162537869	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs74986430	chr6:162537872-162537873	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs141060617	chr6:162537919-162537920	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Parkinson disease	21829596	CNVD
Schizophrenia	23813976	CNVD
Gastric cancer	22315472	CNVD
Autism	19404257	CNVD
Schizophrenia	20967226	CNVD
Schizophrenia	21346763	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
Autism	22495309	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
Schizophrenia	19805367	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:1274 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162525200-162539800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr6:162536400-162543200	Weak transcription	Aorta	Aorta
3	chr6:162537800-162538600	Enhancers	Fetal Stomach	stomach
4	chr6:162538600-162540200	Weak transcription	Fetal Stomach	stomach
5	chr6:162539800-162540000	Enhancers	Psoas Muscle	Psoas
6	chr6:162539800-162540400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr6:162539800-162540600	Enhancers	Skeletal Muscle Male	skeletal muscle
8	chr6:162539800-162541000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr6:162539800-162541000	Enhancers	Muscle Satellite Cultured Cells	--
10	chr6:162539800-162541000	Enhancers	NHDF-Ad	bronchial
11	chr6:162539800-162541200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr6:162539800-162541200	Enhancers	Fetal Muscle Leg	muscle
13	chr6:162539800-162541200	Enhancers	HSMM	muscle
14	chr6:162539800-162541400	Enhancers	Skeletal Muscle Female	skeletal muscle
15	chr6:162539800-162541600	Enhancers	Primary hematopoietic stem cells short term culture	blood
16	chr6:162540000-162540200	Enhancers	Brain Substantia Nigra	brain
17	chr6:162540000-162540600	Weak transcription	Psoas Muscle	Psoas
18	chr6:162540000-162541000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr6:162540000-162541000	Enhancers	Colon Smooth Muscle	Colon
20	chr6:162540000-162541200	Enhancers	Monocytes-CD14+_RO01746	blood
21	chr6:162540000-162541400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr6:162540200-162540600	Enhancers	Right Ventricle	heart
23	chr6:162540200-162540800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr6:162540200-162540800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr6:162540200-162540800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr6:162540200-162540800	Enhancers	Adipose Nuclei	Adipose
27	chr6:162540200-162540800	Enhancers	Fetal Stomach	stomach
28	chr6:162540200-162540800	Enhancers	Left Ventricle	heart
29	chr6:162540200-162540800	Enhancers	Right Atrium	heart
30	chr6:162540200-162541000	Enhancers	Brain Hippocampus Middle	brain
31	chr6:162540200-162541000	Enhancers	HSMMtube	muscle
32	chr6:162540200-162541200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr6:162540200-162541400	Enhancers	Primary monocytes fromperipheralblood	blood
34	chr6:162540200-162543400	Weak transcription	Brain Substantia Nigra	brain
35	chr6:162540400-162540800	Enhancers	Primary hematopoietic stem cells	blood
36	chr6:162540400-162540800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr6:162540400-162540800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr6:162540600-162540800	Enhancers	Psoas Muscle	Psoas
39	chr6:162540800-162541400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr6:162540800-162543200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
41	chr6:162540800-162543200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
42	chr6:162540800-162543200	Weak transcription	Psoas Muscle	Psoas
43	chr6:162540800-162545800	Weak transcription	Right Atrium	heart
44	chr6:162541000-162545000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr6:162541200-162545200	Weak transcription	HSMM	muscle
46	chr6:162543200-162543400	ZNF genes & repeats	Aorta	Aorta
47	chr6:162543200-162543400	Enhancers	Psoas Muscle	Psoas
48	chr6:162543200-162543600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr6:162543200-162544000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr6:162543400-162543800	Enhancers	Brain Substantia Nigra	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links